DUBLIN, Feb 28, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the "Seasonal Influenza Vaccination Market in Lithuania, Estonia, Latvia (Baltic Countries) By (Child & Adult) Forecast" report to their offering.
According to this report, in the Baltic Countries, Lithuania is having the highest seasonal influenza vaccine market share followed by Latvia and Estonia. In terms of children vaccination, Lithuania & Latvia hold nearly 70 percent market share in 2016 whereas, in adult vaccination segments, these two will share more than 95 percent market share by 2022.
This report provides a complete analysis of 3 Baltic Countries (Lithuania, Estonia, Latvia) Seasonal Influenza Vaccine Market (Child & Adult), Number of Vaccinated Population (Child & Adult) and Forecast till 2022. All 3 countries in the report have been studied from 2 viewpoints.
Growth Drivers:
- Vaccine Manufacturers Plan to Increase Flu Vaccine Production
- Growing Children & Ageing Population in Baltic Region
- Rising Healthcare Expenditure Share of the Baltic Countries GDP
Challenges:
- Regulatory Challenges with New and Novel Influenza Vaccines
- Lack of Healthcare Infrastructure
- Limited Reimbursement and Access to the Vaccines
Key Topics Covered:
1. Executive Summary
2. Baltic Countries Seasonal Influenza Vaccinated Population
3. Baltic Countries Seasonal Influenza Vaccine Market
4. Baltic Countries Seasonal Influenza Vaccine Market Share Analysis
5. Estonia
6. Latvia
7. Lithuania
8. Seasonal Influenza Vaccine - Growth Drivers
9. Seasonal Influenza Vaccine - Challenges
For more information about this report visit http://www.researchandmarkets.com/research/5fj3qj/seasonal
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
